维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="SATOUCHI M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer ( NSCLC ) treated with gefitinib 显示文摘	Satouchi M Negoro S Funada Y et at	2007	Br J Cancer2007，96，8：	1
2	Randomized phase IIstudy of two different schedules of gemcitabine and oral S-1 inchemo-naive patients with advanced non-small cell lung cancer显示文摘	Satouchi M Kotani Y Katakami N	2008	J Clin Oncol2008，26，：	1
3	Digestibility,absorptivity,and physiological effects of cellooligosaccharides in human and rat显示文摘	Satouchi M Watanabe T Wakabayashi S	1996	Journal of Japanese Society for Nutritional Food Science1996，49，：	1
4	A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109) 显示文摘	HATTORI Y SATOUCHI M SHIMADA T	2015	Lung Cancer2015，87，2：	1
5	CT fluoroscopy-guided bron- choscopic dye marking for resection of small peripheral pulmonary nodules 显示文摘	Endo M Kotani Y Satouchi M	2004	Chest2004，125，5：	1
6	A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor ( EGFR ) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109 ) 显示文摘	Hattori Y Satouchi M Shimada T	2015	Lung Cancer2015，87，2：	1
7	Inhibitory effect of low-molecular-weight heparin on the bronchoconstriction in ovalbumin-sensitized guinea pigs after antigen exposure显示文摘	Maeda H Yahata T Satouchi M	1995	Arerugi1995，44，11：	1
8	Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLO t rea ted wi thgeni f i t i b 显示文摘	Satouchi M Negoro S Funada Y	2007	Br JCancer2007，96，：	1
9	Inhibitory effect of low-molecular-weight haparin on the broncheconstriction in ovalbumin-sensitized guinea-pigs after antigen exposure 显示文摘	Maeda H Yahata T Satouchi M	1993	Jpn J Allergol1993，44，11：	1
10	Predictive factors associated with prolonged survival in patients with a non-small cell lung cancer (NSCLC) treated with Gefitinib 显示文摘	Satouchi M Negoro S Funada Y	2007	BrJCancer2007，96，8：	1
11	A phase Ⅲ study comparing amrubicin and cisplatin(AP)with irinotecan and cisplatin(IP)for the treatment of extended-stage small cell lung cancer(ED-SCLC):JCOG0509显示文摘	Kotani Y Satouchi M Ando M		0，，：	1
12	Phase Ⅲ study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer:JCOG 0509 显示文摘	SATOUCHI M KOTANI Y SHIBATA T	2014	J Clin Oncol2014，32，12：	1
13	Randomized phase III study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial 显示文摘	Okamoto TH Kashii T Satouchi M	2008	J Clin Oncol2008，，：	1
14	Predictive factors associated with prolonged survival in patients with advanced non- small-cell lung cancer (NSCLC) treated with gefitinib显示文摘	Satouchi M Negoro S Funada Y	2007	Br J Cancer2007，96，8：	1
15	Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naive patients with advanced non-small cell lung cancer显示文摘	Satouchi M Kotani Y Katakami N	2008	J Clin Oncol2008，，44：	1
16	Predictive factors associated with prolonged survival in patients with advanced non - small - cell lung cancer treated with gefitinib 显示文摘	Satouchi M Negero S Funada Y	2007	Br J Cancer2007，96，：	1
17	A phase II study of pemetrexed in chemotherapy-nave elderly patients aged >t 75 years with advanced non-squamous non-small-cell lung cancer(HANSHIN Oncology Group 003)显示文摘	Hattori Y Iwasaku M Satouchi M	2013	Japanese Journal of Clinical Oncology2013，43，12：	1
18	Predictive factors associated with prolonged survival in patients with advanced non-smallcell lung cancer(NSCLC) treated with gefitinib显示文摘	Satouchi M Negoro S Funada Y	2007	Br J Cancer2007，96，8：	1
19	Predictive factors associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib显示文摘	Satouchi M Negoro S Funada Y	2007	Br J Cancer2007，96，8：	1
20	A phase 2 study of be- vacizumab in combination with carboplatin and paclitaxel in pa- tients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors ( HANSHIN On- cology Group 0109) 显示文摘	Hattori Y Satouchi M Shimada T	2015	Lung Cancer2015，87，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示